ArticleACS omega2019
Cytotoxic Activity of Royleanone Diterpenes from
Article in ACS omega, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 40 citations in OpenAlex.
- Bioactive Compounds ofMolecules (Basel, Switzerland) · 2026Review
- Acylhydrobenzoquinones influence the susceptibility of Staphylococcus aureus towards abietanes and the speciation within Plectranthus sensus lato.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026Article
- 7α-acetoxy-6β-hydroxyroyleanone (Roy) modulates IL-6/STAT3/JAK2 mRNA expression and suppresses tumor growth in glioblastoma cell models.Frontiers in pharmacology · 2026Article
- Cytotoxic Activity of Chemical Constituents ofPlants (Basel, Switzerland) · 2025Article
- Extraction optimization and reactivity of 7α-acetoxy-6β-hydroxyroyleanone and ability of its derivatives to modulate PKC isoforms.Scientific reports · 2024Article
- Diterpenes Isolated from Three DifferentACS omega · 2024Article
- Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone fromInternational journal of molecular sciences · 2024Article
- Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone fromMolecules (Basel, Switzerland) · 2024Article
- Computation-guided scaffold exploration of 2Beilstein journal of organic chemistry · 2024Article
- Advances on Natural Abietane, Labdane and Clerodane Diterpenes as Anti-Cancer Agents: Sources and Mechanisms of Action.Molecules (Basel, Switzerland) · 2022Review
- Phytochemical Study and Antiglioblastoma Activity Assessment ofMolecules (Basel, Switzerland) · 2022Article
- CACS medicinal chemistry letters · 2022Article
- Anti-inflammatory activities ofFrontiers in pharmacology · 2022Article
- Abietane Diterpenes of the GenusMolecules (Basel, Switzerland) · 2021Review
- Self-Assembly Nanoparticles of Natural Bioactive Abietane Diterpenes.International journal of molecular sciences · 2021Article
- The Botanical, Chemical and Ethnobotanical Diversity of Southern African Lamiaceae.Molecules (Basel, Switzerland) · 2021Review
- Preliminary Biological Activity Screening ofPharmaceuticals (Basel, Switzerland) · 2021Article
- Antimycobacterial, Cytotoxic, and Antioxidant Activities of Abietane Diterpenoids Isolated fromPlants (Basel, Switzerland) · 2021Article
- Review
- Diterpenoids fromPharmaceuticals (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytotoxicity screenings have identified
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.